BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

530207

BRAWN

img img img img
No Data Available

BRAWN BIOTECH LTD. Share Price Update

As of the latest trading session, BRAWN BIOTECH LTD. share price is currently at ₹ 20.07, which is up by ₹ 0.94 from its previous closing. Today, the stock has fluctuated between ₹ 20.07 and ₹ 20.07. Over the past year, BRAWN BIOTECH LTD. has achieved a return of -9.98 %. In the last month alone, the return has been -9.42 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

BRAWN BIOTECH LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    6.00

  • P/E Ratio (TTM)

    -9.28

  • Beta

    -0.44

  • Book Value / share

    12.34

  • Return on equity

    -41.33%

  • EPS (TTM)

    0.00

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.07

info icon alternate text

BRAWN BIOTECH LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 4.89
Operating Expense 4.91
Net Profit 0.07
Net Profit Margin (%) 1.43
Earnings Per Share (EPS) 0.25
EBITDA 0.10
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 5.80
Operating Expense 5.65
Net Profit 0.24
Net Profit Margin (%) 4.13
Earnings Per Share (EPS) 0.89
EBITDA 0.27
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 2.26
Operating Expense 2.84
Net Profit -0.49
Net Profit Margin (%) -21.68
Earnings Per Share (EPS) -1.65
EBITDA -0.45
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 3.84
Operating Expense 4.28
Net Profit -0.43
Net Profit Margin (%) -11.19
Earnings Per Share (EPS) -1.44
EBITDA -0.40
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 3.30
Operating Expense 3.64
Net Profit -0.34
Net Profit Margin (%) -10.30
Earnings Per Share (EPS) -0.96
EBITDA -0.31
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 13.47
Operating Expense 15.35
Net Profit -1.80
Net Profit Margin (%) -13.36
Earnings Per Share (EPS) -5.87
EBITDA -1.69
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 16.49
Operating Expense 18.12
Net Profit -1.54
Net Profit Margin (%) -9.33
Earnings Per Share (EPS) -5.14
EBITDA -1.44
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 22.23
Operating Expense 22.65
Net Profit -0.87
Net Profit Margin (%) -3.91
Earnings Per Share (EPS) -3.04
EBITDA -0.29
Effective Tax Rate (%) -112.19
Particulars MAR 2022 (Values in Cr)
Revenue 8.62
Operating Expense 10.74
Net Profit -1.64
Net Profit Margin (%) -19.02
Earnings Per Share (EPS) -5.25
EBITDA -2.01
Effective Tax Rate (%) 22.16
Particulars MAR 2021 (Values in Cr)
Revenue 34.98
Operating Expense 35.65
Net Profit -0.55
Net Profit Margin (%) -1.57
Earnings Per Share (EPS) -1.55
EBITDA -0.29
Effective Tax Rate (%) -52.77
Particulars MAR 2025 (Values in Cr)
Book Value / Share 11.21
ROE % -41.33
ROCE % -18.71
Total Debt to Total Equity 0.00
EBITDA Margin -12.48
Particulars MAR 2024 (Values in Cr)
Book Value / Share 16.88
ROE % -21.99
ROCE % -20.47
Total Debt to Total Equity 0.00
EBITDA Margin -8.37
Particulars MAR 2023 (Values in Cr)
Book Value / Share 21.03
ROE % -12.86
ROCE % -5.74
Total Debt to Total Equity 0.00
EBITDA Margin -1.30
Particulars MAR 2022 (Values in Cr)
Book Value / Share 24.07
ROE % -20.49
ROCE % -24.95
Total Debt to Total Equity 0.00
EBITDA Margin -23.20
Particulars MAR 2021 (Values in Cr)
Book Value / Share 29.31
ROE % -6.09
ROCE % -3.49
Total Debt to Total Equity 0.00
EBITDA Margin -0.83
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.19
Total Assets 20.48
Total Liabilities 20.48
Total Equity 3.36
Share Outstanding 3000300
Price to Book Ratio 1.45
Return on Assets (%) -8.49
Return on Capital (%) -51.75
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.39
Total Assets 14.58
Total Liabilities 14.58
Total Equity 5.06
Share Outstanding 3000300
Price to Book Ratio 1.18
Return on Assets (%) -8.54
Return on Capital (%) -24.62
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.43
Total Assets 14.53
Total Liabilities 14.53
Total Equity 6.30
Share Outstanding 3000300
Price to Book Ratio 0.79
Return on Assets (%) -5.97
Return on Capital (%) -13.76
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.22
Total Assets 13.78
Total Liabilities 13.78
Total Equity 7.22
Share Outstanding 3000300
Price to Book Ratio 0.72
Return on Assets (%) -11.92
Return on Capital (%) -22.77
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.39
Total Assets 13.87
Total Liabilities 13.87
Total Equity 8.79
Share Outstanding 3000300
Price to Book Ratio 0.75
Return on Assets (%) -3.96
Return on Capital (%) -6.26
Particulars MAR 2025 (Values in Cr)
Net Income -1.79
Cash from Operations 0.04
Cash from Investing -0.24
Cash from Financing 0.00
Net change in Cash -0.19
Free Cash Flow 0.28
Particulars MAR 2024 (Values in Cr)
Net Income -1.54
Cash from Operations -0.02
Cash from Investing -0.01
Cash from Financing 0.00
Net change in Cash -0.04
Free Cash Flow -0.01
Particulars MAR 2023 (Values in Cr)
Net Income -0.41
Cash from Operations 0.30
Cash from Investing -0.09
Cash from Financing 0.00
Net change in Cash 0.21
Free Cash Flow 0.40
Particulars MAR 2022 (Values in Cr)
Net Income -2.11
Cash from Operations 0.18
Cash from Investing -0.29
Cash from Financing -0.06
Net change in Cash -0.17
Free Cash Flow 0.48
Particulars MAR 2021 (Values in Cr)
Net Income -0.35
Cash from Operations 0.30
Cash from Investing 0.00
Cash from Financing -0.03
Net change in Cash 0.00
Free Cash Flow 0.30
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 27.75 13.60 1.44 212.66 27.02 / 68.00
BLISS GVS PHARMA LTD 171.05 16.49 1.59 1808.38 105.05 / 190.65
CIPLA LTD 1520.55 22.57 3.73 122825.65 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 269.00 7.07 2.02 791.69 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 27.75 22.56 3.86 212.66 27.02 / 68.00
AMRUTAJAN HEALTH LTD 655.35 33.42 5.53 1894.66 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9211.50 99.62 28.82 23028.75 6301.00 / 10653.05
BLISS GVS PHARMA LTD 171.05 23.08 1.63 1808.38 105.05 / 190.65

BRAWN BIOTECH LTD. shareholding pattern

Holding

45.99%
53.65%
0.34%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

BRAWN BIOTECH LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
20.07 4.96 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 19.70
  • 26 Days 20.70
  • 10 Days 20.20
  • 50 Days 20.70
  • 12 Days 20.30
  • 100 Days 20.30
  • 20 Days 20.60
  • 200 Days 19.90
19.12 PIVOT

First Support

19.12

First Resistance

19.12

Second Support

19.12

Second Resistance

19.12

Third Support

19.12

Third Resistance

19.12

RSI

41.38

ADX

16.92

MACD

-0.42

Williams % R

-100.00

Commodity Channel Index (CCI)

-118.27

Date

2025-12-05

Week

7.00

Same Day

1.00

Month

652.00

1 Year

-0.44

3 Year

0.02

Over 1 Month

-9.42%

down

Over 1 Year

-9.98%

down

Over 3 Months

-8.69%

down

Over 3 Years

1.10%

down

Over 6 Months

16.58%

down

Over 5 Years

-2.67%

down

BRAWN BIOTECH LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
12 Sep 2018 1.0 Final 15 Sep 2018 Equity shares
14 Sep 2017 1.5 Final 16 Sep 2017 Equity shares

BRAWN BIOTECH LTD. Share Price

Brawn Biotech Ltd was originally incorporated in the name of Brawn Pharmaceuticals Limited in November, 1985. Thereafter, the name of the Company was changed from Brawn Pharmaceuticals Limited to Brawn Biotech Limited in November, 2010. Brawn , with its inception barely 38 years back has today evolved into a fully integrated, healthcare group, marking its presence in India and across the globe.

The Company possess product registration with major health and govt. institutions throughout India and worldwide. Headed and represented by a team of skilled industry experts with impressive educational backgrounds and broad experience, the Company has spread its wings in expansion in the domestic as well as in the international markets beyond the existing horizon to stand among the leading Indian HealthCare products distribution Companies.

The Company is trading in Herbals, Ayurvedic and Critical Care range of Products along with other pharmaceutical products and distributing them in the overseas market, resulting in tremendous growth in sale and profits of the Company. Presently, the Company is also acting as consignee agent for the supplies to Government Hospitals and institutions.

The Company is into Wholesale of Pharmaceutical and Medical Goods. Their Pharmaceutical Products cover all major product segments like Antibacterials, Cardiovasculars, Antidiabetics, Analgesics, Gastrointestinals, Antifungals, Skin Care, Antipsychotics, Antiasthmatics, Antacids, Antimalarials, and Nutritionals.

Besides a professional and competent team that looks into administration, sales, marketing, maintenance, etc., Brawn is supported by a team of highly qualified and experienced consultants to gain an edge over the others in the market.

Parent organization Indian Private
NSE symbol [-]
Founded 1985
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Brawn Biotech Ltd?

Answer Field

Brawn Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 20.07 as on Dec 08 2025 03:15 PM.

What is the Market Cap of Brawn Biotech Ltd Share?

Answer Field

The market cap of Brawn Biotech Ltd for NSE ₹ 0.00 & for BSE ₹ 6.00 as on Dec 08 2025 03:15 PM.

What is the 52 Week High and Low of Brawn Biotech Ltd?

Answer Field

The 52 Week High and Low of Brawn Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 26.05 and ₹ 15.46.

What is 1 year return for Brawn Biotech Ltd?

Answer Field

The 1 year returns on the stock has been -9.98%.

What is the P/E Ratio of Brawn Biotech Ltd Share?

Answer Field

As on Dec 08 2025 03:15 PM the price-to-earnings (PE) ratio for Brawn Biotech Ltd share is -9.28.

What is the PB ratio of Brawn Biotech Ltd Share?

Answer Field

As on Dec 08 2025 03:15 PM, the price-to-book (PB) ratio for Brawn Biotech Ltd share is 12.34.

How to Buy Brawn Biotech Ltd Share?

Answer Field

You can trade in Brawn Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Brawn Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Brawn Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Brawn Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59